# Rebodis

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/rebodis

- Industry: Medical Devices & Equipment
- Headquarters: Seoul, South Korea
- Website: www.rebodis.com/
- Total disclosed funding: $0.3M
- Latest round: Seed (Jan 7, 2026)
- Investors on record: 1

## About

Rebodis Inc., based in South Korea, specializes in creating advanced AI-driven wearable robotic solutions aimed at enhancing individual mobility and quality of life through innovative technology.Founded in 2025, Rebodis Inc. is dedicated to developing wearable robots that improve mobility for individuals facing physical challenges. The company is headquartered in Seoul, South Korea. The founding team includes Kyu-jin Cho and Sung-sik Yun, who serve as the CEO. Rebodis has completed one investment deal to date, raising KRW 500 million in Seed funding from Bass Ventures on January 7, 2026, which represents the total amount raised by the company.Rebodis specializes in innovative wearable robot technology that enhances the quality of life for users by offering intelligent clothing solutions. Their flagship products feature soft wearable robots that combine advanced robotics with a human-centered design for improved mobility. Utilizing soft robotics technology, these products are made from flexible materials for everyday comfort and usability. The company targets a diverse clientele, especially individuals of all ages who have mobility limitations due to aging or disabilities. Rebodis primarily aims to introduce its solutions in South Korea, Japan, and the United States, addressing the growing demand for assistive technologies.Rebodis generates revenue through direct-to-consumer sales and B2B partnerships, focusing on healthcare and assistive technology sectors. Their business model involves selling flagship products directly to end-users, including healthcare providers, which emphasizes mobility enhancement. Pricing reflects the advanced technology and customization of their products, with possible subscription-based services for ongoing support. Partnering with rehabilitation centers and clinics further facilitates revenue by enabling these institutions to provide innovative solutions for their patients.Rebodis Inc. plans to leverage the KRW 500 million raised in Seed funding to enhance its development capabilities, focusing on advancing product innovation and expanding production capacity. The company is also working on new product designs that will be launched in the near future. Moreover, Rebodis aims to expand its market reach into new geographic regions, specifically targeting markets in Japan and the United States by the end of 2026.

## Funding rounds

- Seed, Jan 7, 2026, $0.3M — Bass Ventures

## Investors

- Bass Ventures (https://capitalatlas.ai/funds/bass-ventures) — Seed